Xue Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xue Jiang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Bo Wang
CAS Key Laboratory of Tibetan Medicine Research Northwest Institute of Plateau Biology Xining China
1 shared publication - Chunjie Zhao
School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, China
1 shared publication Defu Hu
School of Ecology and Nature Conservation Beijing Forestry University Beijing China
1 shared publication- Dong Zhang
Key Laboratory of Non-Invasive Research Technology for Endangered Species, School of Ecology and Nature Conservation, Beijing Forestry University, Beijing 100083, China
1 shared publication - Fei Han
School of Pharmacy, Shenyang Pharmaceutical University, No.103 Wenhua Road, Shenhe District, Shenyang, 110016, China
1 shared publication - Jingwei Li
Department of Respiratory and Critical Care Medicine, Med-X Center for Manufacturing, Frontiers Science Center for Disease-related Molecular Network, West China Medical School/West China Hospital, Sichuan University, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 12 May 2023
- Published by Association for Computing Machinery (ACM)
- p. 303-309
Exploring the lmpacts of Al Technologies on Medical lnstitutions with Knowledge Graphs
- 12 May 2023
- Published by Association for Computing Machinery (ACM)
- p. 303-309
Open AccessExploring the lmpacts of Al Technologies on Medical lnstitutions with Knowledge Graphs
- 1 January 2022
- Published by Elsevier in Microporous and Mesoporous Materials
- Vol. 330, 111634
Alanine modified chiral-responsive mesoporous silica as nanocarriers for improved oral bioavailability of carvedilol
- 1 January 2022
- Published by Elsevier in Microporous and Mesoporous Materials
- Vol. 330, 111634
Alanine modified chiral-responsive mesoporous silica as nanocarriers for improved oral bioavailability of carvedilol
- 14 September 2021
- Published by Wiley in Integrative Zoology
- Vol. 17 (3) , 333-345
Metagenomics reveals contrasting energy utilization efficiencies of captive and wild camels (Camelus ferus)
Captive conditions can affect the symbiotic microbiome of animals. In this study, we compared the structural and functional differences of the gastrointestinal microbiomes of wild Bactrian camels (Camelus ferus) between wild and captive populations, as well as their different host energy utilization performances through metagenomics. The results showed that wild‐living camels harbored more microbial taxa related to the production of volatile fatty acids, fewer methanogens, and fewer genes encoding enzymes involved in methanogenesis, leading to higher energy utilization efficiency compared to that of captive‐living camels. These findings suggest that the wild‐living camel fecal microbiome demonstrates a series of adaptive characteristics that enable the host to adjust to a relatively barren field environment. Our study provides novel insights into the mechanisms of wildlife adaptations to habitats from the perspective of the microbiome.
- 14 September 2021
- Published by Wiley in Integrative Zoology
- Vol. 17 (3) , 333-345
Metagenomics reveals contrasting energy utilization efficiencies of captive and wild camels (Camelus ferus)
Captive conditions can affect the symbiotic microbiome of animals. In this study, we compared the structural and functional differences of the gastrointestinal microbiomes of wild Bactrian camels (Camelus ferus) between wild and captive populations, as well as their different host energy utilization performances through metagenomics. The results showed that wild‐living camels harbored more microbial taxa related to the production of volatile fatty acids, fewer methanogens, and fewer genes encoding enzymes involved in methanogenesis, leading to higher energy utilization efficiency compared to that of captive‐living camels. These findings suggest that the wild‐living camel fecal microbiome demonstrates a series of adaptive characteristics that enable the host to adjust to a relatively barren field environment. Our study provides novel insights into the mechanisms of wildlife adaptations to habitats from the perspective of the microbiome.
- 19 November 2019
- Published by Wiley in Biomedical Chromatography
- Vol. 34 (4) , e4741
Synergistic therapeutic effects of Duzhong Jiangya Tablets and amlodipine besylate combination in spontaneously hypertensive rats using 1H‐NMR‐ and MS‐based metabolomics
Duzhong Jiangya Tablet (DJT) composed of Eucommia ulmoides Oliv. and several other traditional Chinese medicines is a Chinese herbal compound, which is clinically used to treat hypertension. The aim of this study was to evaluate the antihypertensive effect of DJT and amlodipine besylate (AB) on the synergistic treatment of spontaneously hypertensive rats (SHRs), and to explore its antihypertensive mechanism. The synergistic therapeutic effect of DJT in combination with AB on SHR was studied using two metabolomics methods based on mass spectrum (MS) and nuclear magnetic resonance. Metabolomics analysis of plasma, urine, liver, and kidney and the combination of orthogonal partial least squares discriminant analysis was performed to expose potential biomarkers. Then, the overall metabolic characteristics and related abnormal metabolic pathways in hypertensive rats were constructed. Blood pressure measurements showed that DJT combined with AB has better effects in treating hypertension than it being alone. A total of 30 biomarkers were identified, indicating that hypertension disrupted the balance of multiple metabolic pathways in the body, and that combined administration restored metabolite levels better than their administration alone. The changes of biomarkers revealed the synergistic therapeutic mechanism of DJT combined with AB, which provided a reference for the combination of Chinese and Western medicines.
- 19 November 2019
- Published by Wiley in Biomedical Chromatography
- Vol. 34 (4) , e4741
Synergistic therapeutic effects of Duzhong Jiangya Tablets and amlodipine besylate combination in spontaneously hypertensive rats using 1H‐NMR‐ and MS‐based metabolomics
Duzhong Jiangya Tablet (DJT) composed of Eucommia ulmoides Oliv. and several other traditional Chinese medicines is a Chinese herbal compound, which is clinically used to treat hypertension. The aim of this study was to evaluate the antihypertensive effect of DJT and amlodipine besylate (AB) on the synergistic treatment of spontaneously hypertensive rats (SHRs), and to explore its antihypertensive mechanism. The synergistic therapeutic effect of DJT in combination with AB on SHR was studied using two metabolomics methods based on mass spectrum (MS) and nuclear magnetic resonance. Metabolomics analysis of plasma, urine, liver, and kidney and the combination of orthogonal partial least squares discriminant analysis was performed to expose potential biomarkers. Then, the overall metabolic characteristics and related abnormal metabolic pathways in hypertensive rats were constructed. Blood pressure measurements showed that DJT combined with AB has better effects in treating hypertension than it being alone. A total of 30 biomarkers were identified, indicating that hypertension disrupted the balance of multiple metabolic pathways in the body, and that combined administration restored metabolite levels better than their administration alone. The changes of biomarkers revealed the synergistic therapeutic mechanism of DJT combined with AB, which provided a reference for the combination of Chinese and Western medicines.